Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 68.12% is 146% above its 5-year average of -148.73%, near the high end of its 5-year range (-517.43%–78.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 153.89% above its 12-month average of 26.83%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 68.12%.
RETURN ON EQUITY (ROE)
68.12%
RETURN ON EQUITY (ROE) AVG TTM
26.83%
RETURN ON EQUITY (ROE) AVG 3Y
-169.45%
RETURN ON EQUITY (ROE) AVG 5Y
-148.73%
RETURN ON EQUITY (ROE) AVG 10Y
-127.12%
RETURN ON EQUITY (ROE) AVG 15Y
-111.36%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+153.89%
CURRENT VS 3Y AVG
+140.20%
CURRENT VS 5Y AVG
+145.80%
CURRENT VS 10Y AVG
+153.59%
CURRENT VS 15Y AVG
+161.17%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.89%
median of 686 covered companies
CURRENT VS SECTOR MEDIAN
+266.60%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$67.93M
Return on Equity (ROE)
68.12%
TTM Avg
26.83%
3Y Avg
-169.45%
5Y Avg
-148.73%
Market Cap
$67.84M
Return on Equity (ROE)
-38.55%
TTM Avg
-81.03%
3Y Avg
-175.38%
5Y Avg
-133.71%
Market Cap
$69.07M
Return on Equity (ROE)
-250.39%
TTM Avg
-122.53%
3Y Avg
-92.00%
5Y Avg
-67.18%
Market Cap
$69.48M
Return on Equity (ROE)
16.70%
TTM Avg
-67.07%
3Y Avg
-43.48%
5Y Avg
-55.81%
Market Cap
$65.85M
Return on Equity (ROE)
-35.13%
TTM Avg
-26.80%
3Y Avg
-19.63%
5Y Avg
-14.70%
Market Cap
$70.30M
Return on Equity (ROE)
-29.15%
TTM Avg
47.40%
3Y Avg
90.52%
5Y Avg
62.16%
Market Cap
$65.15M
Return on Equity (ROE)
-8.80%
TTM Avg
-13.04%
3Y Avg
-7.69%
5Y Avg
-7.21%
Market Cap
$65.08M
Return on Equity (ROE)
N/A
TTM Avg
-26.44%
3Y Avg
-559.66%
5Y Avg
-417.87%
Market Cap
$65.06M
Return on Equity (ROE)
-122.71%
TTM Avg
-558.46%
3Y Avg
-307.41%
5Y Avg
-314.14%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $67.93M | 68.12% | 26.83% | -169.45% | -148.73% |
| iBio, Inc. (IBIO)vs › | $67.84M | -38.55% | -81.03% | -175.38% | -133.71% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.07M | -250.39% | -122.53% | -92.00% | -67.18% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 16.70% | -67.07% | -43.48% | -55.81% |
| XBiotech Inc. (XBIT)vs › | $65.85M | -35.13% | -26.80% | -19.63% | -14.70% |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | -29.15% | 47.40% | 90.52% | 62.16% |
| InterCure Ltd. (INCR)vs › | $65.15M | -8.80% | -13.04% | -7.69% | -7.21% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | N/A | -26.44% | -559.66% | -417.87% |
| Cingulate Inc. (CING)vs › | $65.06M | -122.71% | -558.46% | -307.41% | -314.14% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.75M | -492.89% | -50.27% | -279.07% | -249.48% |
ROE
68.1%
ROA
35.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 68.12% |
| 2026-03-31 | 78.77% |
| 2025-12-31 | 13.66% |
| 2025-09-30 | 7.14% |
| 2025-06-30 | -33.54% |
| 2025-03-31 | -185.01% |
| 2024-12-31 | -202.30% |
| 2024-09-30 | -229.28% |
| 2024-06-30 | -227.61% |
| 2024-03-31 | -236.77% |
| 2023-12-31 | -268.97% |
| 2023-09-30 | -469.63% |
| 2023-06-30 | -517.43% |
| 2023-03-31 | -244.34% |
| 2022-12-31 | -207.51% |
| 2022-09-30 | -147.87% |
| 2022-06-30 | -115.85% |
| 2022-03-31 | -73.21% |
| 2021-12-31 | -59.54% |
| 2021-09-30 | -41.48% |
| 2021-06-30 | -30.66% |
| 2021-03-31 | -40.58% |
| 2020-12-31 | -46.37% |
| 2020-09-30 | -58.41% |
| 2020-06-30 | -89.19% |
| 2020-03-31 | -144.31% |
| 2019-12-31 | -152.43% |
| 2019-09-30 | -191.31% |
| 2019-06-30 | -166.98% |
| 2019-03-31 | -296.57% |
| 2018-09-30 | -184.47% |
| 2018-06-30 | -182.46% |
| 2018-03-31 | -182.26% |
| 2017-12-31 | -127.21% |
| 2017-09-30 | -200.02% |
| 2017-06-30 | -82.69% |
| 2017-03-31 | -114.92% |
| 2016-12-31 | -143.12% |
| 2016-09-30 | -135.70% |
| 2016-06-30 | -155.30% |
| 2016-03-31 | -109.00% |
| 2015-12-31 | -85.19% |
| 2015-09-30 | -74.81% |
| 2015-06-30 | -47.49% |
| 2015-03-31 | -41.68% |
| 2014-12-31 | -28.91% |
| 2014-09-30 | -38.22% |
| 2014-06-30 | -41.06% |
| 2014-03-31 | -47.25% |
| 2013-12-31 | -45.72% |
| 2013-09-30 | -41.16% |
| 2013-06-30 | -70.28% |
| 2013-03-31 | -111.91% |
| 2012-12-31 | -125.31% |
| 2012-09-30 | -88.11% |
| 2012-06-30 | -68.29% |
| 2012-03-31 | -151.47% |
| 2011-12-31 | -190.05% |
